- Home
- LTRN
LTRN
Lantern Pharma Inc.
as 11-21-2024 4:00pm EST
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | DALLAS |
| Market Cap: | 36.2M | IPO Year: | 2020 |
| Target Price: | N/A | AVG Volume (30 days): | 50.0K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.77 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.79 - $11.99 | Next Earning Date: | 11-07-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Lantern Pharma Inc. News
LTRN Breaking Stock News: Dive into LTRN Ticker-Specific Updates for Smart Investing
Business Wire
3 days ago
Lantern Pharma Announces First Patient Dosed in Japan for The Expansion Cohort in The Phase 2 HARMONIC™ Clinical Trial of LP-300 in Never-Smoker NSCLC Patients
Zacks Small Cap Research
10 days ago
LTRN: Pediatric Rare Cancer in Focus
GuruFocus.com
13 days ago
Lantern Pharma Inc (LTRN) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Rising ...
Business Wire
15 days ago
Lantern Pharma Reports Third Quarter 2024 Financial Results and Business Updates
Business Wire
17 days ago
Starlight Therapeutics Announces Inaugural Members of Scientific Advisory Board
Business Wire
22 days ago
Lantern Pharma to Report Third Quarter 2024 Operating & Financial Results on November 7th, 2024 at 4:30 p.m. ET
Business Wire
a month ago
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2024
Business Wire
a month ago
Lantern Pharma to Host & Participate in Two Public Webinars During October
Compare LTRN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LTRN Lantern Pharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.